A methods of treating an infection comprises administering a therapeutically effective amount of a compound described by the Formula (I): ##STR1## wherein: X may be O, S, or NR' wherein R' is H or loweralkyl, R.sub.1 and R.sub.2 may be independently selected from the group consisting of H, loweralkyl, oxyalkyl, alkoxyalkyl, cycloalkyl, aryl, hydroxyalkyl, aminoalkyl, and alkylaminoalkyl; R.sub.3 and R.sub.4 are each independently selected from the group consisting of H, loweralkyl, halogen, oxyalkyl, oxyaryl, and oxyarylalkyl; R.sub.5 is represented by a formula selected from the group consisting of: ##STR2## wherein: X.sub.1, X.sub.2, and X.sub.3 are independently selected from O and S; and R.sub.6 and R.sub.7 are independently selected from the group consisting of loweralkyl, aryl, alkylaryl, oxyaryl, an ester-containing substituent, and oxyalkyl; or a pharmaceutically acceptable salt thereof.

Los métodos de tratar una infección abarcan administrar una cantidad terapéutico eficaz de un compuesto descrito por el fórmula (i): ## del ## STR1 en donde: X puede ser O, S, o NR ' en donde R ' es H o loweralkyl, R.sub.1 y R.sub.2 se pueden seleccionar independientemente del grupo que consiste en H, loweralkyl, oxyalkyl, alkoxyalkyl, cycloalkyl, el aryl, hydroxyalkyl, aminoalkyl, y alkylaminoalkyl; R.sub.3 y R.sub.4 son cada uno seleccionado independientemente del grupo que consiste en H, loweralkyl, halógeno, oxyalkyl, oxyaryl, y oxyarylalkyl; R.sub.5 es representado por un fórmula seleccionado de consistir en el grupo: ## del ## STR2 en donde: X.sub.1, X.sub.2, y X.sub.3 se seleccionan independientemente de O y de S; y R.sub.6 y R.sub.7 se seleccionan independientemente del loweralkyl que consiste en del grupo, del aryl, del alkylaryl, del oxyaryl, de un sustituto e'ster-que contiene, y de oxyalkyl; o una sal farmacéutico aceptable de eso.

 
Web www.patentalert.com

< (none)

< Method of treating cytotoxic damage

> Absorbent article which maintains or improves skin health

> (none)

~ 00057